Real Talk About Breast Cancer

Today I’m joined by two survivors who experienced menopause at an early age due to breast cancer and treatment. At the time of their diagnoses, Deb Song and Elvira Velez could have carried children. The treatment for their cancer, and subsequent hysterectomies, however, changed their lives forever.

Breast cancer screening and early detection play an important role in your health. Screening tests can help detect breast cancer at an early stage when the chances of survival are the highest. Joining us on the show today to talk about the importance of screening, imaging tests for women for dense breasts and the role of innovation and technology in screening is Henry Izawa, President and CEO of FUJIFILM Healthcare Americas Corporation.

Learning about your breast cancer risk can empower you to make important breast care decisions to take charge of your health. If you are at higher risk of breast cancer, talk with your doctor about a screening plan that’s best for you. You may need to be screened earlier and more often than other women. If genetic test results show that you have an inherited gene mutation, you may also consider risk-lowering options, such as risk-lowering drugs, prophylactic surgeries, or clinical trials. Today’s guest has an extensive family history of both breast and ovarian cancers and tested positive for a BRCA1 mutation at a young age. Here today to tell us her story and how she’s worked with her doctors to create a screening schedule to keep a close eye on things while allowing her to fulfill her life dreams is Amy Hunter.

Komen’s free, virtual 10-week patient navigation training program provides specific training for patient navigators to ensure they can help Black patients overcome barriers to receiving high-quality care and treatment. The patient navigation training program takes a multifaceted approach to addressing inequities and barriers in the health care system, first and foremost by connecting patients to resources and support at every step of their breast care journey. We are excited to discuss how Komen trains patient navigators to be culturally responsive with Kelley Moultry, Komen’s Patient Navigation and Outreach Coordinator.

As we celebrate Black History Month, it is our honor to be joined today by a woman truly making history and one that I know we will be seeing much more from in the future. Dr. Zainab Shonibare, recently graduated from her PhD in 2022, is a reproductive cancer researcher at Yale University and the first Black postdoctoral researcher in her lab. Her story underscores why representation matters and diversity in research is so important, and Dr. Shonibare is here today to share her story and tell us about the focus of her research.

Tomorrow is Valentine’s Day! But we’re kicking things off a day early with a conversation about LOVE and breast cancer. February 14th it isn’t red roses and champagne toasts for everyone, and today’s conversation about LOVE reminds us of that. Se’Nita Harris was diagnosed with aggressive, triple negative breast cancer at age 37, before she found love. LaToya Bolds-Johnson was diagnosed with stage 3C triple negative breast cancer at age 36. She is married with three young girls and struggling to love the skin she’s in after treatment for her breast cancer. Whether you’re in love or looking to find love breast cancer changes you – physically, emotionally, mentally, sexually. Ladies, thank you for being on today’s show to talk about your own personally struggles to love and be loved.